Conference Coverage
Conference Coverage
Racial disparities in cardiotoxicity after chemotherapy
“The most important message is to look at preexisting cardiovascular disease, oncology diagnosis, and be aware of existing disparities in a...
Conference Coverage
African ancestry genetically linked to worse CRC outcomes
Results from a new study provide greater clarity regarding the genetic piece of the puzzle.
Conference Coverage
Durvalumab pre, post surgery in NSCLC: Practice changing?
A new study’s findings confirm the benefits of neoadjuvant immunotherapy.
Conference Coverage
AI predicts endometrial cancer recurrence
Model uses only digitized histopathology slides, but more validation in other populations is needed.
Conference Coverage
PARP/ATR inhibitor combo shows hints of promise in children with tumors
A phase 1 clinical trial could provide biomarker clues to help guide future studies.
Conference Coverage
Circulating DNA has promise for cancer detection, but faces challenges
Unnecessary procedures and health care challenges could leave Whites as the primary beneficiaries.
Conference Coverage
Relapsed CLL: New approaches prolong survival
Venetoclax, with a second-generation generation Bruton’s tyrosine kinase inhibitor, can lead patients with relapsed CLL back to remission.
Conference Coverage
Pembrolizumab monotherapy effective for rare melanoma
Patients with unresectable desmoplastic melanoma experienced a response rate that was nearly double other melanomas.
Latest News
Insurers refusing MRI for women at high risk for breast cancer
Compared with 2020, there were significantly more denials, and denials on appeal, in 2021. The addition of MRI to mammography is a standard...
Latest News
What happens to melanocytic nevi during laser hair removal?
“It’s important to keep an eye out for changes and always be evaluating,” Dr. Ahuva Cices said.
Conference Coverage
Study gives new insight into timing of combo treatment in metastatic NSCLC
Best outcomes came when immunotherapy followed radiotherapy by 1-12 months.